Daniel Lee

Daniel Lee is a highly experienced scientist currently serving as Scientist 1 at Life Edit Therapeutics since January 2024, following a role as Senior Research Associate II at Beam Therapeutics from February 2021 to November 2023, where expertise was applied in LNP Discovery and Process Development. Notably, Daniel optimized processes for BEAM 301 and 302 pipelines and led the development of novel LNPs for gene delivery. Prior to Beam, Daniel contributed to high throughput LNP screening at Guide Therapeutics and completed extensive research during a PhD program at the University of Illinois at Chicago. Daniel's educational background includes a Master of Science in Bioengineering from both the University of Illinois Chicago and Carnegie Mellon University, along with a Bachelor of Science in Biomedical Engineering from Washington University in St. Louis.